TransMedics Group Inc (TMDX) Shares Surge 3.2% -- What GF Score of 69 Tells Investors

gurufocus.com · 2026-09-04

On September 03, 2026, TransMedics Group Inc (TMDX) shares rose 3.2% to a current price of $86.98, which is situated within a 52-week range of $60.11 to $156.00

TickrTrends take: TransMedics Group Inc operates in the Healthcare sector, where valuation metrics become particularly important given the capital-intensive nature of medical device development and commercialization. According to TickrTrends' current assessment, TMDX is considered undervalued, which aligns with investor interest reflected in recent price movements. A GF Score of 69 suggests moderate fundamental quality that warrants attention from valuation-focused investors monitoring whether the current undervaluation thesis remains sustainable as the company executes its business strategy.

Read the full story at gurufocus.com →